⏳
Showing Q4 2023 data
Endurant Capital Management LP's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Endurant Capital Management LP
•CIK: 1633055•Filing: Q4 2023
**Endurant Capital Management LP** manages $17M across a concentrated portfolio of 25 positions. The fund exhibits notable allocations to healthcare and specialized sectors, with top holdings including BSX at $2.3M and TMO at $2.0M. Further significant exposure is maintained in PFG ($1.5M) and ELV ($1.2M). This structure suggests a tactical, high-conviction approach within select market segments.
Total AUM
$17.4M
QoQ Performance
N/A
Positions
25
Top 10 Concentration
70.1%
Latest Filing
Q4 2023
Top Holdings Allocation
BSX
TMO
AXNXUSD
ELV
ICLR
LABO
BSX13.0%
TMO11.5%
AXNXUSD8.9%
ELV7.1%
ICLR5.9%
LABORATORY5.2%
EHC4.9%
PODD4.9%
📈 Biggest Buys
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other82.2%
Healthcare17.8%